Schizophrenia Research
Volume 122, Issue 1 , Pages 31-37 , September 2010

Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls

  • Katrine V. Wirgenes

      Affiliations

    • Institute of Psychiatry, University of Oslo, Oslo, Norway
    • Department of Psychiatry, Oslo University Hospital— Ulleval, Oslo, Norway
    • ,
  • Srdjan Djurovic

      Affiliations

    • Institute of Psychiatry, University of Oslo, Oslo, Norway
    • Department of Medical Genetics, Oslo University Hospital — Ulleval, Oslo, Norway
    • Department of Psychiatry, Oslo University Hospital— Ulleval, Oslo, Norway
    • ,
  • Kjetil Sundet

      Affiliations

    • Institute of Psychology, University of Oslo, Oslo, Norway
    • ,
  • Ingrid Agartz

      Affiliations

    • Institute of Psychiatry, University of Oslo, Oslo, Norway
    • Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
    • ,
  • Morten Mattingsdal

      Affiliations

    • Institute of Psychiatry, University of Oslo, Oslo, Norway
    • ,
  • Lavinia Athanasiu

      Affiliations

    • Institute of Psychiatry, University of Oslo, Oslo, Norway
    • Department of Medical Genetics, Oslo University Hospital — Ulleval, Oslo, Norway
    • Department of Psychiatry, Oslo University Hospital— Ulleval, Oslo, Norway
    • ,
  • Ingrid Melle

      Affiliations

    • Institute of Psychiatry, University of Oslo, Oslo, Norway
    • Department of Psychiatry, Oslo University Hospital— Ulleval, Oslo, Norway
    • ,
  • Ole A. Andreassen

      Affiliations

    • Institute of Psychiatry, University of Oslo, Oslo, Norway
    • Department of Psychiatry, Oslo University Hospital— Ulleval, Oslo, Norway
    • Corresponding Author InformationCorresponding author. Psychosis Research Section — TOP, Building 49, Division of Psychiatry, Oslo University Hospital — Ulleval, Kirkeveien 166, N-0407 Oslo, Norway. Tel.: +47 23 02 73 50; fax: +47 23 02 73 33.

Received 17 December 2009 ,Revised 14 April 2010 ,Accepted 7 May 2010.

References 

  1. Barnett JH, Heron J, Ring SM, Golding J, Goldman D, Xu K, et al. Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am. J. Psychiatry. 2007;164:142–149
  2. Barnett JH, Scoriels L, Munafo MR. Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol. Psychiatry. 2008;64:137–144
  3. bi-Dargham A. Do we still believe in the dopamine hypothesis? New data bring new evidence. Int. J. Neuropsychopharmacol. 2004;7(Suppl. 1):S1–S5
  4. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 2004;75:807–821
  5. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr. Bull. 2006;32:9–16
  6. Craddock N, Owen MJ, O'Donovan MC. The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Mol. Psychiatry. 2006;11:446–458
  7. Crow TJ. Nature of the genetic contribution to psychotic illness—a continuum viewpoint. Acta Psychiatr. Scand. 1990;81:401–408
  8. Daban C, Martinez-Aran A, Torrent C, Tabares-Seisdedos R, Balanza-Martinez V, Salazar-Fraile J, et al. Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review. Psychother. Psychosom. 2006;75:72–84
  9. Delis DC, Kaplan E, Kramer JH. Delis–Kaplan Executive Function System (D-KEFS) Norwegian Manual. Stockholm: Pearson Assessment; 2005;
  10. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test — Second Edition (CVLT-II). Norwegian Manual supplement. Stockholm: Pearson Assessment; 2004;
  11. Diaz-Asper CM, Goldberg TE, Kolachana BS, Straub RE, Egan MF, Weinberger DR. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Biol. Psychiatry. 2008;63:72–79
  12. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001;98:6917–6922
  13. Fan JB, Zhang CS, Gu NF, Li XW, Sun WW, Wang HY, et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol. Psychiatry. 2005;57:139–144
  14. Glatt SJ, Faraone SV, Tsuang MT. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case–control and family-based studies. Am. J. Psychiatry. 2003;160:469–476
  15. Goldman D, Weinberger DR, Malhotra AK, Goldberg TE. The role of COMT Val158Met in cognition. Biol. Psychiatry. 2009;65:e1–e2
  16. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry. 2003;160:636–645
  17. Gutierrez B, Bertranpetit J, Guillamat R, Valles V, Arranz MJ, Kerwin R, et al. Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. Am. J. Psychiatry. 1997;154:113–115
  18. Haatveit, B.C., Sundet, K., Hugdal, K., Ueland, T., Melle, I., & Andreaasen, O.A. (in press, accepted December 2009) The validity of d-prime as a working memory index: Results from the “Bergen n-back task”. Journal of Clinical and Experimental Neuropsychology. doi:10.1080/13803391003596421.
  19. Hardy J, Singleton A. Genomewide association studies and human disease. N. Engl. J. Med. 2009;360:1759–1768
  20. Harrison PJ, Tunbridge EM. Catechol-O-Methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology. 2007;33:3037–3045
  21. Hill SK, Harris MS, Herbener ES, Pavuluri M, Sweeney JA. Neurocognitive allied phenotypes for schizophrenia and bipolar disorder. Schizophr. Bull. 2008;34:743–759
  22. Hoenicka J, Garrido E, Martinez I, Ponce G, Aragues M, Rodriguez-Jimenez R, et al. Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009;153B:79–85
  23. Kunugi H, Vallada HP, Hoda F, Kirov G, Gill M, Aitchison KJ, et al. No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene. Biol. Psychiatry. 1997;42:282–285
  24. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6:243–250
  25. Mata I, Arranz MJ, Staddon S, Lopez-Ilundain JM, Tabares-Seisdedos R, Murray RM. The high-activity Val allele of the catechol-O-methyltransferase gene predicts greater cognitive deterioration in patients with psychosis. Psychiatr. Genet. 2006;16:213–216
  26. Matsumoto M, Weickert CS, Akil M, Lipska BK, Hyde TM, Herman MM, et al. Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience. 2003;116:127–137
  27. Mier D, Kirsch P, Meyer-Lindenberg A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol. Psychiatry. 2009;doi:10.1038/mp.2009.36
  28. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E, et al. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol. Psychiatry. 2009;14:252–260
  29. Munafo MR, Bowes L, Clark TG, Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case–control studies. Mol. Psychiatry. 2005;10:765–770
  30. Nolan KA, Bilder RM, Lachman HM, Volavka J. Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am. J. Psychiatry. 2004;161:359–361
  31. O'Donovan MC, Craddock NJ, Owen MJ. Genetics of psychosis; insights from views across the genome. Hum. Genet. 2009;126:3–12
  32. O'Hara R, Miller E, Liao CP, Way N, Lin X, Hallmayer J. COMT genotype, gender and cognition in community-dwelling, older adults. Neurosci. Lett. 2006;409:205–209
  33. Pooley EC, Fineberg N, Harrison PJ. The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive–compulsive disorder in men: case–control study and meta-analysis. Mol. Psychiatry. 2007;12:556–561
  34. Prata DP, Mechelli A, Fu CH, Picchioni M, Kane F, Kalidindi S, et al. Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. Biol. Psychiatry. 2009;65:473–480
  35. Prata DP, Mechelli A, Fu CH, Picchioni M, Toulopoulou T, Bramon E, et al. Epistasis between the DAT 3′ UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2009;106:13600–13605
  36. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007;81:559–575
  37. Rybakowski JK, Borkowska A, Czerski PM, Hauser J. Eye movement disturbances in schizophrenia and a polymorphism of catechol-O-methyltransferase gene. Psychiatry Res. 2002;113:49–57
  38. Rypma B. Factors controlling neural activity during delayed-response task performance: testing a memory organization hypothesis of prefrontal function. Neuroscience. 2006;139:223–235
  39. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci. 1998;18:2697–2708
  40. Shifman S, Bronstein M, Sternfeld M, Pisante A, Weizman A, Reznik I, et al. COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004;128B:61–64
  41. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch. Gen. Psychiatry. 1992;49:624–629
  42. Tan HY, Callicott JH, Weinberger DR. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb. Cortex. 2007;17(Suppl. 1):i171–i181
  43. Tan HY, Chen Q, Sust S, Buckholtz JW, Meyers JD, Egan MF, et al. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc. Natl. Acad. Sci. U. S. A. 2007;104:12536–12541
  44. Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur. J. Biochem. 1994;223:1049–1059
  45. Ventura J, Liberman RP, Green MF, Shaner A, Mintz J. Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res. 1998;79:163–173
  46. Wechsler D. Wechsler Memory Scale — Third Edition (WMS-III). Norwegian Manual. Stockholm: Pearson Assessment; 2007;
  47. Wechsler D. Wechsler Adult Intelligence Scale — Third Edition (WAIS-III). Norwegian Manual. Stockholm: Pearson Assessment; 2003;
  48. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, et al. Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry. 2001;50:825–844
  49. Xie T, Ho SL, Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol. Pharmacol. 1999;56:31–38

PII: S0920-9964(10)01303-4

doi: 10.1016/j.schres.2010.05.007

Schizophrenia Research
Volume 122, Issue 1 , Pages 31-37 , September 2010

Article Tools

* Image Usage & Resolution